GBPCGlobal Botanical Pharmaceutical Corporation

Nature. Science. People.

Botanical science.
A healthier future.

Global Botanical Pharmaceutical Corporation brings botanical research and product development together to explore new possibilities in health and wellness.

GBPC presentation artwork showing a globe, botanical leaves and a handshake
Rooted in nature. Guided by research.Botanical platforms and modern delivery technology.

Meet GBPC

Connecting nature
with modern science.

GBPC focuses on botanical pharmaceutical and nutraceutical development: turning plant-based research into potential health products.

The company’s overview describes work across brain health, vision and metabolic health, alongside oral film delivery technology. It also highlights a partnership with the American Botanical Drug Association (ABDA).

Read the company overview ↗

Explore GBPC & partnerships ↗

Our science

Three areas of focus.

A simple introduction to the botanical platforms described in the GBPC presentation.

01 / BRAIN HEALTH

Gastrodin™

Research & development

A botanical research platform focused on neurodegeneration and cognitive health. The presentation references IND 62,518.

Explore the research ↗
02 / VISION HEALTH

SSL™ technology

Delivery platform

A liposome and micelle delivery approach described for botanical ingredients including lutein and astaxanthin.

Explore the technology ↗
03 / METABOLIC HEALTH

SBD™ Bitter Melon

Botanical platform

A bitter melon platform presented as part of GBPC’s work in metabolic health and botanical product development.

Explore the platform ↗

These descriptions summarize the supplied presentation. An IND reference does not mean a product has FDA approval.

Explore all research topics ↗

Delivery made simpler

A small strip.
A different approach.

GBPC’s oral dissolving film strip technology is designed as an alternative to swallowing a conventional pill or capsule.

  1. 01 A compact, portable format
  2. 02 Designed to dissolve in the mouth
  3. 03 A delivery approach for botanical formulations

Select the image for a closer look.

Explore delivery & formulations ↗

Product concepts

From platform to possibility.

Explore three oral film strip concepts featured in the presentation.

MacuCare™

A vision-focused oral film strip concept featuring lutein SSL™ technology.

Brain Regen™

A brain health oral film strip concept featuring micronized gastrodin.

GlucoBotanics™

A metabolic health oral film strip concept featuring sustained-release bitter melon.

Product imagery and descriptions come from the presentation. Availability and regulatory status are not confirmed on this website.

Explore product presentations ↗

IPO & asset value

The business opportunity.

Asset values and growth plans reported in the GBPC overview presentation.

Combined reported asset value$1.01 billion

Across three flagship botanical platforms.

BRAIN HEALTH

Gastrodin™

$230 million

Reported value of the neurological health platform, referenced in the presentation alongside IND 62,518.

METABOLIC HEALTH

SBD™ Bitter Melon

$210 million

Reported value of the diabetes and metabolic health platform.

VISION HEALTH

Lutein-SSL™

$570 million

Reported value of the advanced vision health platform and SSL delivery technology.

Source: presentation, page 2, which attributes these values to Grant Thornton China. The underlying valuation report and valuation date were not supplied. These are reported asset values, not a verified current company valuation, share price or expected investment return. Explore the asset portfolio ↗

IPO ambition

Gastrodin oral film strips

The presentation describes Gastrodin’s oral dissolving film strip platform as positioned for IPO-driven expansion.

No IPO filing, exchange, ticker, listing date or offer price is provided in the presentation. This section describes the stated ambition; it does not confirm an active public offering.

Explore the IPO plans ↗
Proposed growth funding

$30 million capital raise

The presentation proposes funding research, formulation development, manufacturing, regulatory work and commercialization.

  • Research & development · 30%$9.0M
  • Manufacturing scale-up · 25%$7.5M
  • Formulation development · 20%$6.0M
  • Commercialization & expansion · 15%$4.5M
  • Regulatory activities · 10%$3.0M
Explore the funding plan ↗
View revenue projectionsIllustrative figures from the presentation, following commercialization

Year 1: $40 million
Commercial launch & market entry

Year 2: $80 million
Oral film strip market expansion

Year 3: $340 million
Accelerated revenue growth

These are projections from page 25, not actual revenue or guaranteed results. The presentation does not assign calendar years to these figures. Explore the revenue projections ↗

Explore business & growth plans ↗

Our people

Experience across disciplines.

Research, business, finance and operations. Select a name to read a short biography.

Dr. Yaguang Liu
Dr. Yaguang LiuFounder Emeritus

Helped establish GBPC’s botanical research foundation. His work connected traditional botanical knowledge with molecular pharmacology and drug development.

Full biography in presentation ↗
David Allen, PhD
David Allen, PhDCo-Founder · Chairman & Chief Scientific Officer

Co-founder of the American Botanical Drug Association, with a background in botanical research partnerships, technology entrepreneurship and wellness.

Full biography in presentation ↗
John G. Tobin
John G. TobinCo-Founder · President & CEO

More than 30 years of experience in healthcare management, corporate strategy, international business and product development. Creator of Strip Melts® oral thin film strips.

Full biography in presentation ↗
Jonathan S. Lu, MBA
Jonathan S. Lu, MBACo-Founder · Executive Vice President

Experience in financial analysis, strategic planning, sustainable finance and advanced analytics. Holds an MBA from NYU Stern and a BS in Accounting from Rutgers University.

Full biography in presentation ↗
Dan Liu, MS
Dan Liu, MSCo-Founder · Funding Associate

Brings experience in technology, sales and business development, with degrees in electrical engineering and computer science.

Full biography in presentation ↗
Robert Montano, Esq.
Robert Montano, Esq.Co-Founder · Legal & Corporate Counsel

More than two decades of experience in contract negotiation, corporate compliance and regulatory compliance. Holds degrees from Vanderbilt, Belmont and Hamilton College.

Full biography in presentation ↗
Joseph M. Griesser
Joseph M. GriesserCo-Founder · CFO & Business Operations

A 40-year career across public accounting, financial reporting and business operations. Founder and managing partner of Rago, Griesser & Company.

Full biography in presentation ↗
Ron G. Lu, CPA, MBA, CGMA
Ron G. Lu, CPA, MBA, CGMACo-Founder · Global Funding & Investment

An entrepreneur and finance professional with experience in international business relationships and investment.

Full biography in presentation ↗
Carole L. Tobin
Carole L. TobinChief Administrative Officer

Experience in publishing, corporate leadership, partnerships and global nutraceutical and pharmaceutical businesses.

Full biography in presentation ↗
Barbara A. Allen
Barbara A. AllenChief Communications Officer

A leadership trainer and organizer with experience in administration, fiscal management, operations and wellness education.

Full biography in presentation ↗
Explore leadership & full biographies ↗

Take a closer look

The complete GBPC overview.

Explore the presentation for detailed science, company background, leadership biographies and business plans.

Explore the presentation ↗